Cargando…

Projected Lifetime Healthcare Costs Associated with HIV Infection

OBJECTIVE: Estimates of healthcare costs associated with HIV infection would provide valuable insight for evaluating the cost-effectiveness of possible prevention interventions. We evaluate the additional lifetime healthcare cost incurred due to living with HIV. METHODS: We used a stochastic compute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagawa, Fumiyo, Miners, Alec, Smith, Colette J., Simmons, Ruth, Lodwick, Rebecca K., Cambiano, Valentina, Lundgren, Jens D., Delpech, Valerie, Phillips, Andrew N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406522/ https://www.ncbi.nlm.nih.gov/pubmed/25901355 http://dx.doi.org/10.1371/journal.pone.0125018

Ejemplares similares

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014)

Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic
por: Phillips, Andrew N., et al.
Publicado: (2013)

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries
por: Cambiano, Valentina, et al.
Publicado: (2015)

Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
por: Nakagawa, Fumiyo, et al.
Publicado: (2016)

Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting
por: Phillips, Andrew N., et al.
Publicado: (2014)

Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy
por: Lodwick, Rebecca K., et al.
Publicado: (2015)

Update on HIV in Western Europe
por: Nakagawa, Fumiyo, et al.
Publicado: (2014)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment
por: Miners, Alec, et al.
Publicado: (2019)

Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
por: Baggaley, Rebecca F, et al.
Publicado: (2017)

Modelling the Potential Population Impact and Cost-Effectiveness of Self-Testing for HIV: Evaluation of Data Requirements
por: Cambiano, Valentina, et al.
Publicado: (2014)

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
por: Phillips, Andrew N, et al.
Publicado: (2016)

Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2016)

EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment
por: Vandewalle, Björn, et al.
Publicado: (2016)

Estimating lifetime healthcare costs with morbidity data
por: Carreras, Marc, et al.
Publicado: (2013)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care
por: Revill, Paul, et al.
Publicado: (2018)

A method to estimate the number of people in a country or region with HIV who are undiagnosed and in need of ART
por: Lodwick, RK, et al.
Publicado: (2010)

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017)

Cost‐per‐diagnosis as a metric for monitoring cost‐effectiveness of HIV testing programmes in low‐income settings in southern Africa: health economic and modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2019)

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
por: Phillips, Andrew N, et al.
Publicado: (2019)

Trends in HIV incidence between 2013–2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study
por: Hanum, Nadia, et al.
Publicado: (2021)

Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial
por: Li, Bernadette, et al.
Publicado: (2018)

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
por: Phillips, Andrew N., et al.
Publicado: (2016)

Inequalities in receipt of mental and physical healthcare in people with dementia in the UK
por: Cooper, Claudia, et al.
Publicado: (2017)

In vivo fluorescence lifetime optical projection tomography
por: McGinty, James, et al.
Publicado: (2011)

A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury
por: Williams, Jack, et al.
Publicado: (2022)

Costly Infidelity: Low Lifetime Fitness of Extra-Pair Offspring in a Passerine Bird
por: Hsu, Yu-Hsun, et al.
Publicado: (2014)

A randomised controlled trial of a telephone administered brief HIV risk reduction intervention amongst men who have sex with men prescribed post-exposure prophylaxis for HIV after sexual exposure in the UK: Project PEPSE
por: Llewellyn, Carrie Diane, et al.
Publicado: (2019)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project
por: Sinha, Arjun, et al.
Publicado: (2021)

The HIV epidemic: global and United Kingdom trends
por: Delpech, Valerie
Publicado: (2022)

90‐90‐90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe – 2017 to 2020
por: Bansi‐Matharu, Loveleen, et al.
Publicado: (2018)

The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology
por: Webb, Neil, et al.
Publicado: (2020)

Projecting Cost Containment in the Operating Room Utilizing Incentivized Strategies to Reduce Healthcare Cost
por: Koppert, Tanner, et al.
Publicado: (2019)

Economic evaluation of tranexamic acid for the treatment of acute gastrointestinal bleeding: a cost-effectiveness analysis using data from the HALT-IT randomised controlled trial
por: Bazeer, Nuha, et al.
Publicado: (2022)

Body mass index and lifetime healthcare utilization
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study
por: Devine, Angela, et al.
Publicado: (2021)

Lifetime Health Care Costs of the Danish Population
por: Sørensen, Jan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lu3id5c0nssb2n57kg020c6rii